Rimcazole Clinical Trial at Shandon Clinic – IMB Report
03 October 2011
The Irish Medicines Board (IMB) has today published the findings of its investigation into the conduct of a clinical trial using rimcazole hemifumarate at the Shandon Clinic in August 2010.
This investigation was initiated by the IMB after three subjects participating in the trial experienced seizures. All three subjects recovered fully when the administration of the trial medication was discontinued.
The IMB is the competent authority for the regulation of medicines in Ireland. It is a statutory function of the IMB to assess applications from sponsors to conduct clinical trials.
IMB Rimcazole Trial Report